Home Tools
Log in
Cart

Search Result

Search Results for " bone "

20

Compounds

Cat No. Product Name Synonyms Targets
T1973 PFI-4 PFI4 Epigenetic Reader Domain
PFI-4 is a potent and selective and cell-permeable BRPF1 bromodomain inhibitor.
T1850 Balicatib AAE581 Cysteine Protease
Balicatib (AAE581) is a potent and selective inhibitor of cathepsin K, used in trials studying the treatment of osteoporosis.
T5751 Tigogenin Others
Tigogenin is one of steroidal sapogenins which is widely used for synthesizing steroid drugs. It might have protective effect on bone and be helpful in preventing the development of osteoporosis.
T22702 CYM 50769 Neuropeptide W
CYM 50769 is a neuropeptide W/B receptor 1 (NPBWR1, GPR7) antagonist(IC50 = 0.12 μM). CYM 50769 inhibited NPW activation of NPBWR1 with a submicromolar IC50, and displayed high selectivity against a broad array of off-ta...
T8550 NDMC101 Others , NF-κB , Proteasome
NDMC101 is an inhibitor of dipeptidyl peptidase-IV activity in human T cells and exhibits immunomodulatory effects. It also acts as a novel inhibitor of NFATc1 and NF-κB activity.
T7469 Alendronic Acid alendronate Others
Alendronic Acid (alendronate) is a nonhormonal medication used for osteoporosis, osteogenesis imperfecta, and several other bone diseases.
T5S2129 Sciadopitysin TNF , NF-κB
Sciadopitysin may prevent the development of diabetic osteopathy, it exerts its therapeutic effects via upregulation of mitochondrial biogenesis.Sciadopitysin shows protective effects on antimycin A-induced toxicity in o...
T39508 KY-02327 Others
KY-02327, a metabolically stabilized analog of KY-02061, serves as a potent inhibitor of the Dishevelled (Dvl)-CXXC5 interaction. This compound activates the Wnt/β-catenin pathway, thereby promoting osteoblast differenti...
T38776 LP-922056 Wnt/beta-catenin
LP-922056 is an inhibitor of Notum Pectinacetylesterase with EC50 values of 21 nM, 55 nM for human and mouse, respectively.
T2121 SW033291 Dehydrogenase
SW033291 is a small-molecule inhibitor of 15-PGDH (Ki=0.1 nM) that increases prostaglandin PGE2 levels in bone marrow and other tissues.
T5575 Cycloastragenol Cyclogalegenol,Astramembrangenin Epigenetic Reader Domain , Telomerase
Astramembrangenin (Cycloastragenol (Astramembrangenin)) is a triterpenoid saponin compound and a hydrolysis product of the main active ingredient in Astragalus membranaceus. Cycloastragenol (CAG) may have a novel therape...
T21616 L-006235 L 006235 Cysteine Protease
L-006235 is a potent and reversible inhibitor of cathepsin K with IC50 of 0.25 nM.
TN1494 Cimicifugoside H-1 Others
Cimicifugoside H1 shows the protective function to cerebral neuron during cerebral ischemia.
T1867 Otenaproxesul ATB 346 Apoptosis , COX
Otenaproxesul (ATB 346) is a novel hydrogen sulphide-releasing derivative of naproxen with markedly reduced toxicity.
T8645 PF-06446846 Others
PF 06446846 is a potent and selective PCSK9 inhibitor
T16159 Muramyl dipeptide MDP NOD
Muramyl dipeptide (MDP) is a synthetic immunoreactive peptide, consisting of N-acetyl muramic acid attached to a short amino acid chain of L-Ala-D-isoGln. Muramyl dipeptide indirectly decreases osteoclast differentiation...
T6574 Lumiracoxib Prexige,COX-189 COX
Lumiracoxib (Prexige) is a novel, selective COX-2 inhibitor with IC50 and Ki of 0.14 μM and 0.06 μM, exhibits 515-fold selectivity over COX-1. Phase 4.
T13324 VUF11207 fumarate CXCR , Arrestin
VUF11207 fumarate is an agonist of CXCR7 and a high-potency ligand of CXCR7 (pKi: 8.1).
T2334 Avanafil TA1790 PDE
Avanafil (TA1790) is a selective inhibitor of phosphodiesterase type 5 (PDE5) and is used as therapy of erectile dysfunction.
T4S0969 Obtusifolin Antioxidant , NF-κB
1. Obtusifolin has antioxidant properties and improves chemically induced diabetes and its complications by modulation of oxidative stress. 2. Obtusifolin suppresses phthalate esters-mediated bone resorption, thus may be...
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18
TargetMol